3.238.71.155
dgid:
enl:
npi:0

Search Results

You are searching for: thyroid eye disease

Teprotumumab study finds mixed response rates for active thyroid eye disease

Teprotumumab therapy for active thyroid eye disease demonstrates variable response rates and limited long-term improvement, based on data from a...

Read More

New model predicts the course of inactive thyroid eye disease

A predictive model has been developed to identify potential risk factors influencing the progression of inactive thyroid eye disease (TED),...

Read More

Unique clinical patterns emerge in pediatric thyroid eye disease cases

Pediatric thyroid eye disease (TED) exhibits distinct clinical features compared to adult TED, according to a poster presented at AAO...

Read More

Three-year follow-up highlights continuing struggles for patients with thyroid eye disease

Amongst patients treated for thyroid eye disease, an early reduction in clinical activity score (CAS), a commonly used measure, did...

Read More

Choroidal thickening may be an indicator of disease activity in thyroid eye disease

Using swept-source optical coherence tomography (SS-OCT) revealed that subfoveal choroidal thickness (SFCT) is significantly thicker in patients with active thyroid-associated...

Read More

Teprotumumab therapy shows sustained proptosis improvement in clinical thyroid eye disease

Teprotumumab therapy has shown significant effectiveness in reducing proptosis in patients with clinical thyroid eye disease (TED), with nearly 90%...

Read More

Study looks at thyroid eye disease research in a global context

A new analysis shows that thyroid eye disease (TED) research is a globally collaborative effort, drawing expertise from various medical...

Read More

Teprotumumab shows promise in thyroid eye disease regardless of disease duration

Teprotumumab, an inhibitor of the insulin-like growth factor 1 receptor (IGF-1R), has shown significant promise in treating thyroid eye disease...

Read More

Teprotumumab shows links to hearing changes in patients with thyroid eye disease

A considerable proportion of patients with thyroid eye disease (TED) treated with teprotumumab experienced hearing loss that met criteria for...

Read More

Teprotumumab, tocilizumab effective in treating steroid-resistant thyroid eye disease

Teprotumumab and tocilizumab have shown promise as effective alternatives for treating moderate to severe thyroid eye disease (TED) in patients...

Read More

Teprotumumab shows promise in treating chronic-low clinical activity score thyroid eye disease

Teprotumumab can significantly improve proptosis in patients with chronic thyroid eye disease (TED) who have low levels of inflammation, according...

Read More

Teprotumumab shows promising results in integrated trials for thyroid eye disease

Results from the European Union (EU) study sites of the clinical trial program evaluating teprotumumab for the treatment of thyroid...

Read More

Corneal changes may help identify thyroid eye disease earlier

Thyroid eye disease (TED)-related corneal changes may help diagnose TED, especially "silent" TED, earlier, according to a study. This retrospective...

Read More